Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis

NCT04036721 · clinicaltrials.gov ↗

PHASE4

Phase

SUSPENDED

Status

85

Enrollment

OTHER

Sponsor class

Stopped SARS-CoV-2 cases stopped the recruitment in Organisation since July 2020

Conditions

Lung Neoplasm Malignant
Interstitial Lung Disease

Interventions

DRUG: Prolonged glucocorticosteroid (prednisone) regimen
DRUG: Short glucocorticosteroid (prednisone) regimen

Sponsor

National Institute for Tuberculosis and Lung Diseases, Poland